These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
342 related items for PubMed ID: 25812352
1. Complement 1q (C1q) antibodies levels in sera of Egyptian patients with lupus nephritis. Elshweikh SA, Elkhouly RM, Shaalan MM, Shorbagy SH. Egypt J Immunol; 2014; 21(2):49-59. PubMed ID: 25812352 [Abstract] [Full Text] [Related]
2. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA. Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009 [Abstract] [Full Text] [Related]
3. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement. Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G. Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989 [Abstract] [Full Text] [Related]
4. Anti-C1q antibodies in lupus nephritis and their correlation with the disease activity. Emad G, Al-Barshomy SM. Saudi J Kidney Dis Transpl; 2020 Oct; 31(2):342-352. PubMed ID: 32394906 [Abstract] [Full Text] [Related]
5. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients. Katsumata Y, Miyake K, Kawaguchi Y, Okamoto Y, Kawamoto M, Gono T, Baba S, Hara M, Yamanaka H. Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094 [Abstract] [Full Text] [Related]
6. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Trendelenburg M, Lopez-Trascasa M, Potlukova E, Moll S, Regenass S, Frémeaux-Bacchi V, Martinez-Ara J, Jancova E, Picazo ML, Honsova E, Tesar V, Sadallah S, Schifferli J. Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491 [Abstract] [Full Text] [Related]
7. Negative anti-C1q antibody titers may influence therapeutic decisions and reduce the number of renal biopsies in systemic lupus erythematosus. Moura CG, Mangueira CL, Cruz LA, Cruz CM. Nephron Clin Pract; 2011 Nov; 118(4):c355-60. PubMed ID: 21325866 [Abstract] [Full Text] [Related]
8. Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis. Yin Y, Wu X, Shan G, Zhang X. Lupus; 2012 Sep; 21(10):1088-97. PubMed ID: 22777943 [Abstract] [Full Text] [Related]
9. Association between the presence of anti-C1q antibodies and active nephritis in patients with systemic lupus erythematosus. Gargiulo Mde L, Gómez G, Khoury M, Collado MV, Suárez L, Álvarez C, Sarano J. Medicina (B Aires); 2015 Sep; 75(1):23-8. PubMed ID: 25637896 [Abstract] [Full Text] [Related]
10. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance. Sinico RA, Radice A, Ikehata M, Giammarresi G, Corace C, Arrigo G, Bollini B, Li Vecchi M. Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534 [Abstract] [Full Text] [Related]
11. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4. Julkunen H, Ekblom-Kullberg S, Miettinen A. Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294 [Abstract] [Full Text] [Related]
12. Do circulating antibodies against C1q reflect the activity of lupus nephritis? Smykał-Jankowiak K, Niemir ZI, Polcyn-Adamczak M. Pol Arch Med Wewn; 2011 Sep; 121(9):287-95. PubMed ID: 21860370 [Abstract] [Full Text] [Related]
13. Correlation between the renal C1q deposition and serum anti-C1q antibody: a potential role of anti-C1q antibody in lupus nephritis. Chen PC, Wang CR, Liu MF, Chen FF, Liang CC. Asian Pac J Allergy Immunol; 2002 Dec; 20(4):223-7. PubMed ID: 12744622 [Abstract] [Full Text] [Related]
14. Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares. Matrat A, Veysseyre-Balter C, Trolliet P, Villar E, Dijoud F, Bienvenu J, Fabien N. Lupus; 2011 Jan; 20(1):28-34. PubMed ID: 20943718 [Abstract] [Full Text] [Related]
15. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis]. Zhang FC, Zhou B, Dong Y. Zhonghua Yi Xue Za Zhi; 2005 Apr 13; 85(14):955-9. PubMed ID: 16061001 [Abstract] [Full Text] [Related]
16. Anti-C1q antibodies, sCD40L, TWEAK and CD4/CD8 ratio in systemic lupus erythematosus and their relations to disease activity and renal involvement. ElGendi SS, El-Sherif WT. Egypt J Immunol; 2009 Apr 13; 16(1):135-48. PubMed ID: 20726330 [Abstract] [Full Text] [Related]
17. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis. Sjöwall C, Olin AI, Skogh T, Wetterö J, Mörgelin M, Nived O, Sturfelt G, Bengtsson AA. Autoimmunity; 2013 May 13; 46(3):205-14. PubMed ID: 23331132 [Abstract] [Full Text] [Related]
18. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus. Zivković V, Stanković A, Cvetković T, Mitić B, Kostić S, Nedović J, Stamenković B. Srp Arh Celok Lek; 2014 May 13; 142(7-8):431-6. PubMed ID: 25233687 [Abstract] [Full Text] [Related]
19. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro. Pang Y, Yang XW, Song Y, Yu F, Zhao MH. Immunobiology; 2014 Dec 13; 219(12):980-9. PubMed ID: 25092568 [Abstract] [Full Text] [Related]
20. Antibodies against C1q Are a Valuable Serological Marker for Identification of Systemic Lupus Erythematosus Patients with Active Lupus Nephritis. Chi S, Yu Y, Shi J, Zhang Y, Yang J, Yang L, Liu X. Dis Markers; 2015 Dec 13; 2015():450351. PubMed ID: 26549923 [Abstract] [Full Text] [Related] Page: [Next] [New Search]